What is the appropriate workup for a patient with an elevated total globulin?

Workup for Elevated Total Globulin

Order serum protein electrophoresis with immunofixation immediately to identify whether the elevated globulin represents a monoclonal or polyclonal pattern, as this single test determines the entire diagnostic pathway forward. 1

Initial Laboratory Assessment

The first step is distinguishing between monoclonal versus polyclonal hyperglobulinemia, which have completely different etiologies and urgency levels:

Core Initial Tests

• Serum protein electrophoresis (SPEP) with immunofixation - identifies monoclonal proteins (M-spikes) 1
• Nephelometric quantification of immunoglobulins (IgG, IgA, IgM) - complements electrophoresis and quantifies specific immunoglobulin levels 1
• Complete blood count with differential - look for rouleaux formation, circulating plasma cells, cytopenias 1
• Comprehensive metabolic panel - assess calcium (hypercalcemia), creatinine (renal insufficiency), albumin, liver function 1
• Serum-free light chains with kappa/lambda ratio 1

If Monoclonal Pattern Detected

This suggests plasma cell dyscrasia and requires urgent hematology evaluation. The International Myeloma Working Group guidelines provide clear diagnostic criteria 1:

Proceed immediately with:

• 24-hour urine collection for protein electrophoresis and immunofixation (not random urine) 1
• Bone marrow aspirate and biopsy with CD138 staining to quantify plasma cells 1
• Cytogenetics - both metaphase karyotype and FISH for del(17p), t(4;14), t(14;16) 1
• Skeletal bone survey (spine, pelvis, skull, humeri, femurs) - look for lytic lesions 1
• Serum β2-microglobulin and LDH for prognostic staging 1

Critical thresholds to distinguish entities:

• MGUS: M-protein <3 g/dL, bone marrow plasma cells <10%, no end-organ damage
• Smoldering myeloma: M-protein ≥3 g/dL and/or plasma cells ≥10%, no end-organ damage
• Symptomatic myeloma: Plasma cells ≥10% PLUS end-organ damage (hypercalcemia ≥11.5 mg/dL, creatinine ≥2 mg/dL, hemoglobin <10 g/dL or 2g below normal, or bone lesions) 1

If Polyclonal Pattern Detected

Polyclonal hypergammaglobulinemia has a broader differential and is generally less urgent 2:

Assess for eight major categories systematically:

1. Liver disease (most common) - check AST, ALT, bilirubin, PT/INR, consider hepatitis serologies and imaging. Hyperglobulinemia correlates with ICG clearance and represents impaired hepatic removal of immunoglobulins 3

2. Autoimmune disease/vasculitis - check ANA, RF, anti-CCP, complement levels, ESR

3. Infection/chronic inflammation - measure C-reactive protein. Persistently elevated CRP ≥30 mg/L suggests IL-6-mediated inflammation driving the hyperglobulinemia 2

4. IgG4-related disease - measure IgG subclasses. IgG4 >5 g/L is ~90% specific for IgG4-related disease, though mild elevations occur in many conditions 2

5. Haematological disorders - consider lymphoma, CLL, Castleman disease

6. Non-haematological malignancy - age-appropriate cancer screening

7. Immunodeficiency syndromes - HIV testing, consider autoimmune lymphoproliferative syndrome, histiocyte disorders in appropriate clinical context 2

8. Iatrogenic - recent IVIG administration (can transiently elevate globulins and cause false-positive antibody tests) 4

Clinical Context Matters

Calculated globulin thresholds provide screening guidance 5, 6:

• ≥42 g/L: 42% had paraproteins when SPEP performed 5
• ≥50 g/L: Associated with liver disease (37%), haematological malignancy (36%), autoimmune disease (13%), or infections (9%) 5
• Median 50 g/L: Seen in active multiple myeloma (78.6% higher than controls) 6

Common Pitfalls to Avoid

• Never rely on random urine samples - always use 24-hour collection for accurate M-protein quantification 1
• Don't skip immunofixation - perform even if no visible peak on electrophoresis, as light chain disease may be missed 1
• Bromocresol green vs purple methods affect albumin measurement and thus calculated globulin - be aware of your lab's methodology 7
• Don't assume benign - even asymptomatic monoclonal proteins require bone marrow evaluation to distinguish MGUS from smoldering myeloma 1
• Check medication history - recent IVIG can cause transient antibody elevations lasting 1-2 months 4

The pattern on SPEP (monoclonal vs polyclonal) is the critical branch point that determines whether you're dealing with a potentially life-threatening plasma cell disorder requiring immediate hematology referral versus a more indolent inflammatory or hepatic process.